StockNews.com assumed coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Stock Performance Shares of RDHL opened at $0.43 on Friday. RedHill Biopharma has a 1 year low of $0.26 and a 1 year […]
RedHill Biopharma (NASDAQ:RDHL – Get Free Report) and Iterum Therapeutics (NASDAQ:ITRM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Risk and Volatility RedHill Biopharma has a […]
StockNews.com started coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Trading Up 7.4 % Shares of RedHill Biopharma stock opened at $0.45 on Thursday. The company’s fifty day simple moving average is $0.52 […]
By Chris Wack RedHill Biopharma shares were recently up 24% to $1.64 after the company said its two novel investigational drugs, opaganib and RHB-107,.